Targeted Carrier Screening for Thalassemia, Hereditary Deafness, and Spinal Muscular Atrophy: A Feasible Approach for Preventing Birth Defects in China's Community Healthcare System
Molecular Genetics & Genomic Medicine · 2026
DOI: 10.1002/mgg3.70196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2026. Verfasst von Zhihui Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Wenzhou Central Hospital, Wenzhou, China. Hauptthemen laut MEDLINE: Genetic Carrier Screening, Muscular Atrophy, Spinal, Thalassemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wenzhou Science and Technology Program Project.
Abstract (Originalsprache)
Background
While carrier screening is crucial for preventing birth defects, a significant gap exists between comprehensive screening guidelines and the practical barriers—cost, complexity, and compliance—faced by community healthcare in China. This study evaluates the real‐world feasibility and clinical effectiveness of a targeted screening program for thalassemia, hereditary deafness, and spinal muscular atrophy in community health settings in China.
Methods
A total of 7068 pregnant women attending the prenatal clinic at Wenzhou Central Hospital underwent genetic carrier screening from February 2020 to June 2024. The screening focused on hotspot variants using NMPA‐approved kits. A two‐tiered counseling model was implemented, and clinical effectiveness was assessed via a four‐year follow‐up using hospital and birth defect registries.
Results
The screening program identified 1067 carriers, with an overall carrier rate of 15.1%. Among 72 couples with pathogenic variants in the same gene, 12 fetuses were found to be at “abnormal risk.” Crucially, the four‐year follow‐up revealed no false‐negative cases for the targeted severe conditions, demonstrating high clinical effectiveness and a robust negative predictive value.
Conclusion
This targeted screening program is a clinically effective, cost‐conscious, and regulatively compliant framework for preventing severe genetic disorders in China. By strategically balancing clinical impact with economic and logistical realities, this model provides a valuable, replicable approach to improving maternal and child health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Wenzhou Central Hospital, Wenzhou, China.
- Department of Central Laboratory, Wenzhou Central Hospital, Wenzhou, China.
- Department of Prenatal Diagnosis, Wenzhou Central Hospital, Wenzhou, China.
- Zhejiang Key Laboratory of Digital Technology in Medical Diagnostics, Hangzhou, China.
- Yikon Genomics Co. Ltd, Shanghai, China.
ORCID-Profile: Xutao Hong
Förderung
- Wenzhou Science and Technology Program Project
Zitieren
APA
Wang, Z., Bai, W., Cai, X., Huang, S., Zeng, J., Liang, X., & Hong, X. (2026). Targeted Carrier Screening for Thalassemia, Hereditary Deafness, and Spinal Muscular Atrophy: A Feasible Approach for Preventing Birth Defects in China's Community Healthcare System. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70196
Vancouver
Wang Z, Bai W, Cai X, Huang S, Zeng J, Liang X, et al. Targeted Carrier Screening for Thalassemia, Hereditary Deafness, and Spinal Muscular Atrophy: A Feasible Approach for Preventing Birth Defects in China's Community Healthcare System. Molecular Genetics & Genomic Medicine. 2026. doi:10.1002/mgg3.70196
BibTeX
@article{Wang2026,
author = {Wang, Zhihui and Bai, Wenjing and Cai, Xiaohe and Huang, Sheng and Zeng, Jiangzhong and Liang, Xiaoting and Hong, Xutao},
title = {Targeted Carrier Screening for Thalassemia, Hereditary Deafness, and Spinal Muscular Atrophy: A Feasible Approach for Preventing Birth Defects in China's Community Healthcare System},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
doi = {10.1002/mgg3.70196}
}
EUVIMED